Editorial: Reviews in receptor-receptor interactions as novel targets for drug development.
作者信息
Guidolin Diego, Marcoli Manuela, Woods Amina S
机构信息
Department of Neuroscience, Section of Anatomy, University of Padova, Padova, Italy.
Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy.
出版信息
Front Endocrinol (Lausanne). 2023 Mar 24;14:1185190. doi: 10.3389/fendo.2023.1185190. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Reviews in receptor-receptor interactions as novel targets for drug development.社论：受体-受体相互作用作为药物开发新靶点的综述
Front Endocrinol (Lausanne). 2023 Mar 24;14:1185190. doi: 10.3389/fendo.2023.1185190. eCollection 2023.
2
G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.G蛋白偶联受体寡聚化：对G蛋白激活和细胞信号传导的影响。
Circ Res. 2004 Jan 9;94(1):17-27. doi: 10.1161/01.RES.0000110420.68526.19.
3
Functional crosstalk between GPCRs: with or without oligomerization.GPCR 之间的功能串扰：是否有寡聚化。
Curr Opin Pharmacol. 2010 Feb;10(1):6-13. doi: 10.1016/j.coph.2009.10.009. Epub 2009 Dec 3.
4
Hetero-oligomerization of chemokine receptors: diversity and relevance for function.趋化因子受体的异型寡聚化：多样性及其功能相关性。
Curr Med Chem. 2013;20(20):2524-36. doi: 10.2174/09298673113209990117.
5
Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.胰岛素/胰岛素样生长因子-1 受体与 G 蛋白偶联受体信号系统的串扰：二甲双胍治疗胰腺癌的新靶点。
Clin Cancer Res. 2010 May 1;16(9):2505-11. doi: 10.1158/1078-0432.CCR-09-2229. Epub 2010 Apr 13.
6
Understanding the role of heteroreceptor complexes in the central nervous system.了解异受体复合物在中枢神经系统中的作用。
Curr Protein Pept Sci. 2014;15(7):647. doi: 10.2174/138920371507140916122738.
7
The transmembrane domains of GPCR dimers as targets for drug development.G蛋白偶联受体二聚体的跨膜结构域作为药物开发的靶点。
Drug Discov Today. 2023 Jan;28(1):103419. doi: 10.1016/j.drudis.2022.103419. Epub 2022 Oct 26.
8
Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: Focus on heteroreceptor complexes and related functional neurotrophic effects.脑内受体酪氨酸激酶（RTKs）和 G 蛋白偶联受体（GPCR）之间的串扰：关注异源受体复合物及相关的功能性神经营养作用。
Neuropharmacology. 2019 Jul 1;152:67-77. doi: 10.1016/j.neuropharm.2018.11.018. Epub 2018 Nov 13.
9
The Dynamics of GPCR Oligomerization and Their Functional Consequences.G 蛋白偶联受体寡聚化及其功能后果的动力学。
Int Rev Cell Mol Biol. 2018;338:141-171. doi: 10.1016/bs.ircmb.2018.02.005. Epub 2018 Apr 7.
10
Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics.利用偏向的 G 蛋白偶联受体信号转导开发更安全和个体化的治疗药物。
Molecules. 2019 May 29;24(11):2052. doi: 10.3390/molecules24112052.
本文引用的文献
1
Allosteric modulation as a unifying mechanism for receptor function and regulation.变构调节作为受体功能和调节的统一机制。
Diabetes Obes Metab. 2017 Sep;19 Suppl 1:4-21. doi: 10.1111/dom.12959.
2
The dopamine D(4) receptor, the ultimate disordered protein.多巴胺D(4)受体，终极的无序蛋白质。
J Recept Signal Transduct Res. 2010 Oct;30(5):331-6. doi: 10.3109/10799893.2010.513842.
3
Functional crosstalk between GPCRs: with or without oligomerization.GPCR 之间的功能串扰：是否有寡聚化。
Curr Opin Pharmacol. 2010 Feb;10(1):6-13. doi: 10.1016/j.coph.2009.10.009. Epub 2009 Dec 3.
Zotero 插件